Cargando…
Associations of BAFF rs2893321 polymorphisms with myasthenia gravis susceptibility
BACKGROUND: Myasthenia gravis (MG) is an autoimmune diseases characterized by fatigue and weakness of skeletal muscles. B-lymphocyte-activating factor (BAFF), an essential factor for B cell differentiation and development, is important in the progression of MG. The current study aimed to investigate...
Autores principales: | Deng, Hui, Wang, Jianjian, Kong, Xiaotong, Zhang, Huixue, Wang, Tianfeng, Tian, Wenqi, Yi, Tingting, Wang, Lihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822419/ https://www.ncbi.nlm.nih.gov/pubmed/31666013 http://dx.doi.org/10.1186/s12881-019-0906-8 |
Ejemplares similares
-
Competitive endogenous RNA network and pathway-based analysis of LncRNA single-nucleotide polymorphism in myasthenia gravis
por: Wang, Tianfeng, et al.
Publicado: (2021) -
Identification of LINC00173 in Myasthenia Gravis by Integration Analysis of Aberrantly Methylated- Differentially Expressed Genes and ceRNA Networks
por: Xu, Si, et al.
Publicado: (2021) -
Identification of the regulatory role of lncRNA HCG18 in myasthenia gravis by integrated bioinformatics and experimental analyses
por: Li, Shuang, et al.
Publicado: (2021) -
Construction of an miRNA-regulated drug-pathway network reveals drug repurposing candidates for myasthenia gravis
por: Cao, Yuze, et al.
Publicado: (2017) -
LncRNA OIP5-AS1 modulates the proliferation and apoptosis of Jurkat cells by sponging miR-181c-5p to regulate IL-7 expression in myasthenia gravis
por: Wang, Xu, et al.
Publicado: (2022)